Anew Labs offers a China-based rival to AI labs, Endpoints 11 winner says

Endpoints News reported on September 25, 2026, that Anew Labs has been named a winner in the outlet’s Endpoints 11 for 2026, an annual list the publication uses to flag notable private biotech and life-sciences ventures. According to the report, Anew Labs distinguishes itself by offering a China-based alternative within a field where American technology companies, including Google, Anthropic and OpenAI, have shown strong interest.

The dispatch frames Anew Labs’ selection as notable precisely because the company sits outside the cluster of United States-based AI labs that have dominated recent attention in this sector. Endpoints News did not, in the material available, detail the specific technology, funding history or leadership of Anew Labs beyond identifying it as China-based and naming it among this year’s Endpoints 11 honorees.

The report situates the announcement against a broader backdrop in which large American technology firms have poured resources into artificial intelligence applications relevant to the life sciences, a trend the piece describes as ongoing interest rather than a settled outcome. Anew Labs’ inclusion on the list is presented as evidence that comparable ambitions are being pursued outside the United States as well.

No further financial figures, executive statements or product details were included in the portion of the Endpoints News report supplied. The bulletin desk notes this is a developing story and further particulars from Endpoints News may clarify Anew Labs’ specific standing relative to its American counterparts.